These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33511941)

  • 1. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
    Yan G; Luo J; Han X; Zhang W; Pu C; Zhou M; Zhong X; Hou X; Hou MZ; Li R
    Anticancer Agents Med Chem; 2021; 21(17):2351-2367. PubMed ID: 33511941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Synthesis of Novel Coumarin Conjugated Acetamides as Promising Anticancer Agents: An In Silico and In Vitro Approach.
    Mamatha SV; Belagali SL; Bhat M; Kumbar VM
    Anticancer Agents Med Chem; 2021; 21(11):1431-1440. PubMed ID: 32664844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.
    Luo G; Muyaba M; Lyu W; Tang Z; Zhao R; Xu Q; You Q; Xiang H
    Bioorg Med Chem Lett; 2017 Feb; 27(4):867-874. PubMed ID: 28110871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and evaluation of novel coumarin-dithiocarbamate derivatives (IDs) as anti-colorectal cancer agents.
    Zhu H; Ying S; Zhou B; Hu X; Liang X; Li W; Wang D; Jin H; Pan Y
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):593-604. PubMed ID: 33557648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
    Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
    Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
    Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
    Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
    Ma CC; Liu ZP
    Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
    Elshemy HAH; Zaki MA
    Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer Properties of a New Hybrid Analog AD-013 Combining a Coumarin Scaffold with an α-methylene-δ-lactone Motif.
    Dlugosz A; Gach-Janczak K; Szymanski J; Deredas D; Krawczyk H; Janecki T; Janecka A
    Anticancer Agents Med Chem; 2018; 18(3):450-457. PubMed ID: 28933263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
    An R; Hou Z; Li JT; Yu HN; Mou YH; Guo C
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30200625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-binding activity and cytotoxic and cell-cycle arrest properties of some new coumarin derivatives: a multispectral and computational investigation.
    Khosravifar F; Dehghan G; Bidoki SK; Mahdavi M
    Luminescence; 2020 Feb; 35(1):98-106. PubMed ID: 31475787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.
    Lv N; Sun M; Liu C; Li J
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4578-4581. PubMed ID: 28888820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents.
    Wang Y; Liu H; Lu P; Mao R; Xue X; Fan C; She J
    Chem Biol Drug Des; 2015 Oct; 86(4):637-47. PubMed ID: 25626768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies.
    Menteşe E; Güner A; Polatlı E; Emirik M; Bektaş H; Kahveci B
    Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000284. PubMed ID: 33146895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis,
    Goud NS; Kanth Makani VK; Pranay J; Alvala R; Qureshi IA; Kumar P; Bharath RD; Nagaraj C; Yerramsetty S; Pal-Bhadra M; Alvala M
    Bioorg Chem; 2020 Apr; 97():103663. PubMed ID: 32106038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of coumarin-based N-hydroxycinnamamide derivatives as novel histone deacetylase inhibitors with anticancer activities.
    Ding J; Liu J; Zhang Z; Guo J; Cheng M; Wan Y; Wang R; Fang Y; Guan Z; Jin Y; Xie SS
    Bioorg Chem; 2020 Aug; 101():104023. PubMed ID: 32650178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Antitumor Evaluation of Some Hybrid Molecules Containing Coumarin and Quinolinone Moieties.
    Rizzk YW; El-Deen IM; Mohammed FZ; Abdelhamid MS; Khedr AIM
    Anticancer Agents Med Chem; 2019; 19(16):2010-2018. PubMed ID: 31566140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents.
    Yu H; Hou Z; Tian Y; Mou Y; Guo C
    Eur J Med Chem; 2018 May; 151():434-449. PubMed ID: 29649740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis and Biological Evaluation of Novel Coumarin-Based Hydroxamate Derivatives as Histone Deacetylase (Hdac) Inhibitors with Antitumor Activities.
    Yang F; Zhao N; Song J; Zhu K; Jiang CS; Shan P; Zhang H
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31311163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.